Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Mead

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Cancer Research|March 1, 1972
The use of dihydrofolate reductase as a signal for scheduling optimal treatment with antileukemic agentsC T Hardesty, D Chen, J A Mead
Biochemical Medicine|June 1, 1972
The physiological disposition of 14C-labeled 5-hydroxy-pyridine-2-carboxaldehyde thiosemicarbazone (NSC-107,392) in miceR Tomchick, E P Weinstein, J A Mead
Cancer Treatment Reports|August 1, 1976
Pharmacology of antitumor agents from higher plantsS M Sieber, J A Mead, R H Adamson
Cancer Treatment Reports|July 1, 1976
Comparative ultrastructure of submaxillary salivary glands from mice treated with cytosine arabinoside, cyclocytidine, and anhydro-ara-5-fluorocytidineR H Liss, M C Charest, J A Mead
Biochemical Pharmacology|October 1, 1971
Effect of pretreatment with methotrexate on the reduction of dihydrohomofolic acid in miceL C Mishra, A S Parmar, J A Mead
Cancer Research|July 1, 1974
Influence of antileukemic (L1210) treatment schedule on disposition of (minus)-emetine hydrochloride (NSC 33669) in normal and leukemic miceA E Auletta, A M Gery, J A Mead
Analytical Biochemistry|August 1, 1972
A method for assessing dihydrofolate reductase inhibition in vivoL C Mishra, A S Parmar, J A Mead
Biochemical Pharmacology|July 1, 1974
Regeneration of tetrahydrohomofolate in cells. Possible basis for antitumor activity of homofolatesL C Mishra, A S Parmar, J A Mead
Cancer Research|March 1, 1970
Distribution studies of tetrahydrohomofolic acid (NSC 89473) in miceL C Mishra, A S Parmar, J A Mead
Cancer Research|September 1, 1972
The effect of route af administration on the distribution of ellipticine in miceC T Hardesty, N A Chaney, J A Mead
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Cancer Research|March 1, 1972
The use of dihydrofolate reductase as a signal for scheduling optimal treatment with antileukemic agentsC T Hardesty, D Chen, J A Mead
Biochemical Medicine|June 1, 1972
The physiological disposition of 14C-labeled 5-hydroxy-pyridine-2-carboxaldehyde thiosemicarbazone (NSC-107,392) in miceR Tomchick, E P Weinstein, J A Mead
Cancer Treatment Reports|August 1, 1976
Pharmacology of antitumor agents from higher plantsS M Sieber, J A Mead, R H Adamson
Cancer Treatment Reports|July 1, 1976
Comparative ultrastructure of submaxillary salivary glands from mice treated with cytosine arabinoside, cyclocytidine, and anhydro-ara-5-fluorocytidineR H Liss, M C Charest, J A Mead
Biochemical Pharmacology|October 1, 1971
Effect of pretreatment with methotrexate on the reduction of dihydrohomofolic acid in miceL C Mishra, A S Parmar, J A Mead
Cancer Research|July 1, 1974
Influence of antileukemic (L1210) treatment schedule on disposition of (minus)-emetine hydrochloride (NSC 33669) in normal and leukemic miceA E Auletta, A M Gery, J A Mead
Analytical Biochemistry|August 1, 1972
A method for assessing dihydrofolate reductase inhibition in vivoL C Mishra, A S Parmar, J A Mead
Biochemical Pharmacology|July 1, 1974
Regeneration of tetrahydrohomofolate in cells. Possible basis for antitumor activity of homofolatesL C Mishra, A S Parmar, J A Mead
Cancer Research|March 1, 1970
Distribution studies of tetrahydrohomofolic acid (NSC 89473) in miceL C Mishra, A S Parmar, J A Mead
Cancer Research|September 1, 1972
The effect of route af administration on the distribution of ellipticine in miceC T Hardesty, N A Chaney, J A Mead
Pageof 4